Flu drug ‘favipiravir’ hailed as effective for treating COVID-19
Category: #health  By Pankaj Singh  Date: 2020-03-19
  • share
  • Twitter
  • Facebook
  • LinkedIn

Flu drug ‘favipiravir’ hailed as effective for treating COVID-19

Medical authorities in China have reportedly announced the effectiveness of a drug called favipiravir in treating COVID-19 disease. The drug has originally been adopted for the treatment of new strains of influenza in Japan. According to reliable sources, coronavirus infected patients in Shenzen who have been treated with the drug, have apparently shown positive outcomes.

As per the statement made by Zhang Xinmin, director of National Center for Biotechnology Development in China, the clinical trials for the favipiravir drug in Shenzen and Wuhan has yielded positive outcomes. 340 patients are said to have participated in the clinical trial of the drug. Zhang further added that this drug could prove effective for the treatment of the deadly coronavirus that has been spreading across the globe. The drug also possesses a high degree of safety for consumption by the infected patients.

Favipiravir, also known as Avigan, is an antiviral drug developed by Fujifilm’s subsidiary against RNA viruses, which has been proved effective for treating flu. The patients who took part in the trial have turned negative for the disease after a median of 4 days, which normally takes nearly 11 days for patients without favipiravir treatment. In addition, X-rays revealed that around 91% of the patients who were treated with the drug have shown improved conditions of their lungs, as compared to the normal level or chances of 62% improvement among patients without the usage of favipiravir.

The World Health Organization (WHO) has declared coronavirus that has been sweeping across the globe as a pandemic and as a global public health emergency. Nearly 200,000 people across the globe have been infected by the deadly virus, with around 8,000 reported deaths. The WHO is also closely monitoring the outbreak due to the alarming levels of severity and spread of the pandemic. Major affected regions outside of the mainland China include Italy, the U.S, and South Korea.

Source credits:

https://www.cnbc.com/2020/03/18/coronavirus-japanese-flu-drug-could-be-effective-in-treating-pandemic.html



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Inzomelid declares positive CAPS treatment results, completes Phase I
Inzomelid declares positive CAPS treatment results, completes Phase I
By Pankaj Singh

Inflammasome biotech company Inflazome has reportedly announced the successful completion of Inzomelid’s Phase I clinical study. In addition, the firm has also declared that it has observed positive results from ...

Flipkart to re-open its online portal to deliver essential products
Flipkart to re-open its online portal to deliver essential products
By Pankaj Singh

Flipkart, a renowned Indian e-commerce company, reportedly announced that it would be re-starting its online portal to deliver essential commodities across India. The company had closed down all its operations on Wedne...

American Furniture Warehouse to offer engaging digital receipts
American Furniture Warehouse to offer engaging digital receipts
By Pankaj Singh

American Furniture Warehouse, one of the leading furniture retail firms in the U.S, has reportedly selected flexEngage, a prominent player in personalized transactional communications, for offering dynamic digital rece...